Yogi Ltd (511702)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹46.27 |
| Market Cap | ₹143.33 Cr |
| P/E Ratio | 37.81 |
| ROCE | 1.92% |
| ROE | 26% |
| Dividend Yield | 0% |
| Profit Growth | 964.71% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹145 — ₹192.2 |
| Sector | Finance |
| Book Value | ₹16.35 |
Strengths
- Reported ROE of 26% suggests the existing book is earning well, if the figure is genuine and sustainable.
- Profit growth of 964.71% has produced a PEG of 0.04, indicating the market is not paying for the recent earnings jump.
- Piotroski F-Score of 6/9 is a reasonable passing score on basic financial health metrics.
- The latest quarter is profitable: ₹2 Cr net profit on ₹57 Cr sales, showing near-term positive momentum.
Concerns
- Sales growth is zero, so the 964.71% profit growth is likely a low-base or margin effect, not business expansion.
- ROCE of 1.92% is alarmingly low for an NBFC, implying poor returns on capital employed.
- The current price of ₹46.27 is far below the stated 52-week range of ₹145.00–₹192.20, which is a serious data inconsistency that must be resolved.
- Missing promoter holding, debt/equity, and zero dividend leave governance and leverage too opaque for a Graham-style investment.
AI Analysis
I begin with what every investor should admit: I do not understand this business from these numbers. Yogi Ltd is a small NBFC, but the financial statements, as presented, do not add up. Today's price, ₹46.27, gives a market cap of ₹143 Cr. That means trailing earnings are around ₹3.8 Cr at a P/E of 37.8. Yet book value of ₹16.35 and a P/B of 2.83 imply ₹50.5 Cr of equity, and ROE of 26% would imply earnings of ₹13.1 Cr. Those figures cannot all be true without adjustments. The latest quarter shows ₹57 Cr sales and only ₹2 Cr net profit, a 3.5% margin. A 964.71% profit jump sounds wonderful, but sales growth is 0.00%; this is not a compounding engine, it is a one-off or base effect. The PEG of 0.04 is built on that spike, not on durable compounding. ROCE of only 1.92% is a terrible return on capital for a lending operation. And I cannot ignore the 52-week range: ₹145.00–₹192.20, far above the current ₹46.27. Either the data is stale or something drastic happened; in both cases, I need the audited detail before writing a cheque. Promoter holding, debt/equity, and dividend yield are absent, so governance and leverage are black boxes. Piotroski 6/9 is decent, but it cannot substitute for economic moat. Benjamin Graham taught me to buy with a margin of safety. At 37.8 times earnings and with flat sales, there is no margin of safety. This looks like a market story, not a business story.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer